Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Tachi-S Co ( (JP:7239) ) has issued an update.
Automotive seat maker TACHI-S Co., Ltd. reported consolidated net sales of ¥194.8 billion for the first nine months of FY2025, down 10.7% year on year, while operating income rose 10.9% to ¥5.6 billion and ordinary income jumped 28.4% to ¥7.1 billion. Net income attributable to owners of the parent was roughly flat at ¥5.1 billion, and the equity ratio improved slightly to 56.4% as total assets reached ¥173.2 billion.
The company reaffirmed its full-year FY2025 forecast, projecting a 7.5% decline in net sales to ¥264.0 billion and a 29.3% drop in net income to ¥8.0 billion, despite a small expected rise in ordinary income, while maintaining an annual dividend forecast of ¥103.80 per share. During the period, two China-based subsidiaries were reclassified as equity-method affiliates following partial equity transfers, a move that may streamline consolidation while preserving exposure to the Chinese market, and there were no changes to dividend or earnings guidance, suggesting management views current headwinds as manageable.
The most recent analyst rating on (JP:7239) stock is a Buy with a Yen2562.00 price target. To see the full list of analyst forecasts on Tachi-S Co stock, see the JP:7239 Stock Forecast page.
More about Tachi-S Co
TACHI-S Co., Ltd. is a Japan-based automotive parts manufacturer listed on the Tokyo Stock Exchange, specializing in the development and production of automobile seats. The company serves global automakers as a key seat systems supplier, with operations and affiliates in multiple regions including China, where it also partners through equity-method affiliates.
Average Trading Volume: 106,746
Technical Sentiment Signal: Buy
Current Market Cap: Yen76.72B
See more insights into 7239 stock on TipRanks’ Stock Analysis page.

